This small-cap ASX share could rise 60%

This small cap could be heading meaningfully higher according to Bell Potter.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you have a high tolerance for risk, then it could be worth checking out the small-cap ASX share in this article.

That's because if the team at Bell Potter is on the money with its recommendation, it could deliver explosive returns over the next 12 months.

Ecstatic woman looking at her phone outside with her fist pumped.

Image source: Getty Images

Which small-cap ASX share?

The small cap that Bell Potter is recommending to clients is Bubs Australia Ltd (ASX: BUB).

It is an early-stage fast-moving consumer goods (FMCG) company with exposure to growing demand for premium foreign sourced infant formula (IMF) products in China and the United States.

Bell Potter notes that Bubs recently held its investor day event and was pleased with what it heard. It explains:

In a short span of time BUB has secured 1.3% share of the US IMF market, with a 9% share in the premium natural segment (a category that grew +44% YoY in 2025). Increasing access to product is a key driver of growth with store exposures grown +27% in 1H26 to 5,558 and an expansion to 8,891 targeted by end FY26. The USFDA approval process for permanent market access is ongoing.

Targeting entry into Vietnam, Canada and Mexico, markets with a combined value of A$3.4Bn and growing at an aggregated forecast rate of ~10% p.a. Replicating some of the success seen in Australia and the US (share of 5.1% and 1.3%, respectively) implies a reasonable level of upside if successful.

Bell Potter was also pleased to see that the small-cap ASX stock has reaffirmed its guidance for FY 2026. This will see revenue of $120 million to $125 million, which is up from $104.5 million in FY 2025.

Big potential returns

According to the note, the broker has retained its speculative buy rating and 18 cents price target on the small-cap ASX stock.

Based on its current share price of 11 cents, this implies potential upside of 64% for investors over the next 12 months.

Bell Potter is bullish on the company due to its belief that FY 2026 will be a transformational year. It explains:

FY26e is a transformational year for BUB, with reported EBITDA projected at $4-6m despite incurring $5m in air freight and tariff related expenses, some of which will dissipate in FY27e. In the near term a +59% expansion in ranging points in the US and market realignment of China IMF channels towards English label formats should support a stronger 2H26e sales outcome.

With the US the primary growth engine of the business, gaining permanent access, is likely to prove a de-risking event from a value standpoint. In the interim, recent quarterly reporting saw BUB continue to materially outperform its US IMF peer group in growth (up +32% YoY in 2Q26 in USD terms vs. sector peer weighted revenue growth of -7% YoY).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Shattered investor with head in hands, with ASX chart in the background.
Share Market News

CSL shares crash, but is a comeback looming?

Has the market become too pessimistic about Australia's biotech giant?

Read more »

Two boys looking at each other while standing by the start line with two schoolgirls.
Share Market News

4 ASX 200 shares I'd buy with $5,000 this week

And they're all tipped to climb higher over the next 12 months.

Read more »

steps to picking asx shares represented by four lightbulbs drawn on chalk board
Opinions

Why I'm planning to re-invest my dividends into this ASX share this week

This business is exactly what I want to invest in...

Read more »

A sad looking scientist sitting and upset about a share price fall.
Share Market News

This ASX 200 healthcare stock has crashed to a multi-year low: Here's why and what's next

Fisher & Paykel Healthcare Corporation shares tumbled another 3% on Friday.

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

Buy, hold, sell: Catapult Sports, Worley, CBA shares

ASX 200 shares deteriorated last week and are in the red for 2026 to date.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
52-Week Highs

Are these ASX shares a buy, hold or sell after rocketing to record highs last week?

These stocks have all doubled in the last year.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

5 things to watch on the ASX 200 on Monday

It could be a poor start to the week for Aussie investors.

Read more »